Citation Impact
Citing Papers
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature
2014
Astrocytes: biology and pathology
2009 Standout
The Metabolic Syndrome in South Asians: Epidemiology, Determinants, and Prevention
2009
An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients
2011
Idiopathic pulmonary fibrosis
2017 Standout
Lung Transplant Airway Hypoxia
2010
Hemoglobin disorders and endothelial cell interactions
2009
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Pulmonary veno-occlusive disease
2016
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
2005 Standout
JC Virus: An oncogenic virus in animals and humans?
2009
Bowel Disorders
2016 Standout
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings
2008
Cystic fibrosis
2016 Standout
Management of patients with hepatitis B who require immunosuppressive therapy
2013
Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis
2010
Pediatric Pulmonary Hypertension
2013
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
2012
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
The metabolic syndrome
2010 Standout
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
Definitions and Diagnosis of Pulmonary Hypertension
2013 Standout
Population-based estimates of transbronchial lung biopsy utilization and complications
2012
Flexible polymer transistors with high pressure sensitivity for application in electronic skin and health monitoring
2013 Standout
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Clinical classification of pulmonary hypertension
2004 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Inflammatory Bowel Disease
2009 Standout
Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice
2007
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
2010
Arterial blood pressure measurement and pulse wave analysis-–their role in enhancing cardiovascular assessment
2009
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
The impact of emphysema in pulmonary fibrosis
2013
Crohn's disease
2016 Standout
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease
2013
Heterogeneity in Combined Pulmonary Fibrosis and Emphysema
2007
Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension
2009
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Herpes Viruses in Transplant Recipients: HSV, VZV, Human Herpes Viruses, and EBV
2010
Tadalafil: A Long-Acting Phosphodiesterase-5 Inhibitor for the Treatment of Pulmonary Arterial Hypertension
2011
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
Sickle-cell disease
2010 Standout
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases
2011
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
2012 Standout
Chronic Lung Allograft Rejection: Mechanisms and Therapy
2009
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
2005
Pulmonary veno-occlusive disease
2008
Incidence of complications in bronchoscopy. Multicentre prospective study of 20,986 bronchoscopies
2016
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Role of fibrin D-dimer testing in emergency medicine
2003
New insights into progressive multifocal leukoencephalopathy
2004
Idiopathic pulmonary fibrosis
2011 Standout
D-Dimer Level and the Risk for Thrombosis in Systemic Lupus Erythematosus
2008
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
2009
The Epidemiology and Geographic Distribution of Nontuberculous Mycobacteria Clinical Isolates from Sputum Samples in the Eastern Region of China
2015
Prevalence and Significance of Coagulation Abnormalities in Community-Acquired Pneumonia
2009
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
2015
Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London
2012
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis
2014
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
2011
Guidelines for the Primary Prevention of Stroke
2014 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
DNA methylation in the central and efferent limbs of the chemoreflex requires carotid body neural activity
2017 StandoutNobel
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Lab-on-Skin: A Review of Flexible and Stretchable Electronics for Wearable Health Monitoring
2017 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension
2010
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Pathophysiology of Sleep Apnea
2010 Standout
The role of hypoxia‐inducible factors in carotid body (patho) physiology
2018 StandoutNobel
The Metabolic Syndrome
2008 Standout
Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC)
2019
Renal grafts from anti‐hepatitis B core‐positive donors: a quantitative review of the literature
2012
Clinical Characteristics and Treatment Outcomes ofMycobacterium kansasiiLung Disease in Korea
2010
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
2012 Standout
Fibrose pulmonar idiopática simultânea a enfisema em pacientes tabagistas
2008
Idiopathic Pulmonary Fibrosis
2018 Standout
Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
2013
PPAR-γ agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis
2007
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study).
2007
Works of David Shitrit being referenced
Itraconazole Prophylaxis in Lung Transplant Recipients Receiving Tacrolimus (FK 506): Efficacy and Drug Interaction
2005
The Significance of Elevated Tumor Markers Among Patients With Idiopathic Pulmonary Fibrosis Before and After Lung Transplantation
2011
Is Routine Chest Radiography After Transbronchial Biopsy Necessary?
2006
Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature
2005
Voriconazole and itraconazole in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction
2010
The 15-Step Oximetry Test: a Reliable Tool to Identify Candidates for Lung Transplantation Among Patients With Idiopathic Pulmonary Fibrosis
2009
Quantitative Lung Perfusion Following Single Lung Transplantation
2007
Outbreak of aspergillosis infections among lung transplant recipients
2006
The prevalence of coronary artery disease in end-stage pulmonary disease: Is pulmonary fibrosis a risk factor?
2009
Clinical and radiological features of Mycobacterium kansasii and other NTM infections
2012
Hyperuricemia as a prognostic factor in pulmonary arterial hypertension
2003
Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: A pilot study
2007
Peripheral Arterial Stiffness and Endothelial Dysfunction in Idiopathic and Scleroderma Associated Pulmonary Arterial Hypertension
2009
Lamivudine Prophylaxis for Hepatitis B Virus Infection After Lung Transplantation
2006
Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection
2008
Pregnancy Outcome in Patients With Pulmonary Arterial Hypertension Receiving Prostacyclin Therapy
2005
Benzodiazepine and opioid sedation attenuate the sympathetic response to fiberoptic bronchoscopy. Prophylactic labetalol gave no additional benefit. Results of a randomized double-blind placebo-controlled study
2008
Pulmonary Mycobacterium kansasii Infection in Israel, 1999–2004
2006
A rapid quantitative D-dimer assay at admission correlates with the severity of community acquired pneumonia
2003
Significance of a Plasma D-dimer Test in Patients with Primary Pulmonary Hypertension
2002
Herpes Zoster After Lung Transplantation: Incidence, Timing, and Outcome
2009
Long-Term Azithromycin Use for Treatment of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients
2005
Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome
2007
Recurrence of Pulmonary Veno-occlusive Disease After Heart-Lung Transplantation
2005
Progressive multifocal leukoencephalopathy in transplant recipients
2004
Diagnostic Value of the D-Dimer Test in Deep Vein Thrombosis: Improved Results by a New Assay Method and by Using Discriminate Levels
2001
The association of OSA with insulin resistance, inflammation and metabolic syndrome
2007
Progressive multifocal leukoencephalopathy in a lung transplant recipient
2003
Fecal Calprotectin as a Predictor of Abnormal Colonic Histology
2007
Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome
2007
Development of Malignancy Following Lung Transplantation
2006
Risk factors for death while awaiting lung transplantation in Israeli patients: 1997–2006
2008
Correlation of vascular endothelial growth factor with the severity of thalassemia intermedia
2008